Announcements Trials
Browse Landscape

Status

Recruiting 4Not yet recruiting 2Terminated 1Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Neoplasms 13Carcinoma, Non-Small-Cell Lung 7Breast Neoplasms 5Prostatic Neoplasms 4Neoplasm Metastasis 3Melanoma 3Carcinoma, Hepatocellular 3Urinary Bladder Neoplasms 2Sarcoma 2Pancreatic Neoplasms 2Neoplastic Cells, Circulating 2Multiple Myeloma 2Lung Neoplasms 2Liver Neoplasms 2Glioblastoma 2Fibrosis 2Colorectal Neoplasms 2Cachexia 2Vascular Malformations 1Uterine Cervical Neoplasms 1Testicular Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Skin Neoplasms 1Renal Insufficiency, Chronic 1Recurrence 1Pneumonia 1Ovarian Neoplasms 1Ovarian Cysts 1Osteosarcoma 1Obesity 1

Interventions

Cisplatin 11Cetuximab 10Radiotherapy 7Fluorouracil 6Docetaxel 5pembrolizumab 4Carboplatin 4figitumumab 3Radiation 3Paclitaxel 3Erlotinib Hydrochloride 3Bleomycin 3130-nm albumin-bound paclitaxel 3talimogene laherparepvec 2avelumab 2Surgical Procedures, Operative 2Oxaliplatin 2Lapatinib 2Capecitabine 2zalutumumab 1yeast-CEA vaccine 1temsirolimus 1temoporfin 1smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic 1selinexor 1remetinostat 1ponatinib 1patritumab 1nilotinib 1necitumumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Carcinoma, Squamous Cell × Blood Specimen Collection × Clear all
NCT00507702 2019-04-18

Identification of Key Blood Molecular Markers for Immunotherapy

Stanford University

Terminated
191 enrolled
Tumor-Agnostic

Adenocarcinoma, Carcinoma, Squamous Cell, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡